RiZE: Stock App by myBiniyog

About RiZE: Stock App by myBiniyog

RiZE – The Official Stock Market App by myBiniyog
SEBI Registered Research Analyst | Registration No: INH000022598
RiZE is a professional stock market education and research app built for Indian investors and traders.
Learn market concepts the right way and access structured, research-based stock updates in one place.
Designed for beginners to advanced users, RiZE focuses on clarity, discipline, and compliance.

KEY FEATURES OF RiZE
1. Research-Based Stock Recommendations
Get structured stock research prepared by a SEBI Registered Research Analyst.
• Swing Trading Ideas: Short-term opportunities based on market structure and technical analysis
• Long-Term Investment Ideas: Stocks identified through business and growth-focused research
• Clear Entry & Exit Levels: Defined zones for action with risk-aware planning
• Transparent Tracking: Past research outcomes shared for informed evaluation
2. Comprehensive Stock Market Courses
Learn trading and investing through step-by-step modules created for real Indian market conditions.
• Basics to Advanced: From candlesticks to technical analysis and risk management
• Strategy Learning: RSI, price action, volume analysis, and practical setups
• Language Friendly: Courses in Bengali and easy English for better understanding
• Education First: Build independent decision-making skills, not dependency

WHY CHOOSE RiZE
• Trusted Brand: Built by the team behind the myBiniyog community
• SEBI Registered Framework: Research process aligned with compliance standards
• User-Friendly Experience: Clean, ad-free interface designed for learning and analysis
• Indian Market Focus: Practical learning and research suited for Indian equities

Download RiZE Today
Start your journey with structured learning and disciplined research.
Learn. Research. RiZE.

Disclaimer: Investments in securities market are subject to market risks. Read all the related documents carefully before investing. RiZE provides educational content and research-based insights only. No assurance of returns is given